BSE · 544013
KK Shah Hospitals Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹10 Cr with net profit ₹-1 Cr — a -6.47% net margin, versus -3.42% the period before.
Shareholding
As of 2026-09-30
- Promoter71.36%
- Public28.64%
349 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.79× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Healthcare · ranked #53 of 87 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Apollo Hospitals Enter. Limited | ₹1,22,591 Cr | 54.13 | 11.55 | 21.14% | 8.12% |
| Max Healthcare Institute Ltd. | ₹92,184 Cr | 64.91 | 8.12 | 12.18% | 15.1% |
| Manipal Health Enterpri Limited | ₹89,630 Cr | 95.57 | 5.44 | 10.59% | 6.87% |
| Aster DM Quality Care Ltd. | ₹62,952 Cr | 113.55 | 8.46 | 7.11% | 7.23% |
| Fortis Healthcare Ltd. | ₹57,679 Cr | 53.73 | 5.51 | 9.91% | 10.48% |
| Global Health Limited | ₹39,095 Cr | 60.38 | 9.04 | 14.3% | 12.24% |
| Narayana Hrudayalaya Ltd. | ₹38,019 Cr | 42.01 | 7.61 | 17.17% | 8.36% |
| Dr. Lal Path Labs Ltd. | ₹33,452 Cr | 55.22 | 12.18 | 21.32% | 19.29% |
| Krishna Institute of Medical Sciences Ltd. | ₹30,646 Cr | 150.75 | 7.79 | 5.4% | 4.62% |
| Dr. Agarwal's Health Care Limited | ₹17,463 Cr | 97.66 | 7.81 | 8.04% | 7.61% |
| KK Shah Hospitals Limited(this company) | ₹29 Cr | — | 2.23 | -58.55% | 7.37% |
AI analysis
AI-generated · google/gemini-2.5-flashKK Shah Hospitals Limited is listed with a market capitalization of Rs 27 Cr. The company reported revenue of Rs 9.55 Cr and a net profit margin of 0% for the most recent period. The 52-week high for the share price is Rs 51.9 and the 52-week low is Rs 29.
Positives
- +The company has a low debt-to-equity ratio of 0.
- +Promoter holding is high at 71.3595% as of March 31, 2026.
Negatives
- −The company reported a negative Return on Equity (ROE) of -486.9%.
- −Return on Capital Employed (ROCE) is negative at -5.6952%.
- −The company experienced a net loss of Rs -0.3272 Cr in Mar 2025, a decrease from a net profit of Rs 0.6072 Cr in Mar 2024.
- −The profit margin is 0% for the most recent period.
- −Earnings per share (EPS) is 0.
Financial Performance
KK Shah Hospitals Limited reported revenue of Rs 9.55 Cr for the latest fiscal year. Net profit stood at Rs -0.3272 Cr for Mar 2025, a decrease from Rs 0.6072 Cr in Mar 2024. Earnings per share (EPS) for the same period was -0.48. In the quarter ending Jun 2023, revenue was Rs 1.62 Cr with a net profit of Rs 0.1 Cr.
Profitability & Returns
The company's Return on Equity (ROE) is -486.9%, indicating significant losses relative to equity. Return on Capital Employed (ROCE) is -5.6952%. The profit margin for the recent period is 0%. The EPS reported is 0.
Balance Sheet
KK Shah Hospitals Limited has a book value of Rs 18.78 per share. The debt-to-equity ratio is 0, indicating the company has no reported debt. No dividend yield is reported for the company (0%).
Ownership & Pledges
As of March 31, 2026, promoters held 71.3595% of the shares. Public shareholding stood at 28.6405%. There is no reported promoter pledge (0%). The number of shareholders as of March 31, 2026, was 362.
Shareholding History
Promoter holding has remained consistent at 71.3595% from Nov 2023 to Mar 2026. However, it decreased from 100% in Mar 2023. Public shareholding, which was 0% in Mar 2023, increased to 28.6405% by Nov 2023 and has remained at that level until Mar 2026.
Data as of — price: 2026-11-14 · financials: Mar 26 · shareholding: Sep 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.